Semaglutide is a glucagon-like peptide-1 (GLP-1) agonist that mimics naturally occurring hormones in your gut that stimulate insulin production and tell your brain that your stomach is full
This benefit appeared independent of weight loss, suggesting direct cardiovascular protective effects from GLP-1 receptor activation
Semaglutide may start working within 1-2 weeks of beginning
Article PubMed Google Scholar Hall, K
Kidney, cardiovascular, and safety outcomes of canagliflozin according to baseline albuminuria: a CREDENCE secondary analysis
236 Lifestyle factors, including nutritional therapy, especially the Mediterranean diet, 237 physical activity, 238,239,240 smoking cessation, 241 and quality sleep, are essential for preventing diabetes and its complications